People · Operator
Named in public records as an officer, director or promoter · active 2007–2014 · Biotech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zivo Bioscience, Inc. | — | Biotech | Series A | $14.6M | $34.1M | 2013 |
| Nephrx Corp | — | Biotechnology | Series A | $6.2M | $224.8M | 2007 |
THOMAS COX at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside THOMAS COX on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Gorman | 1 | 7 |
| JOHN PAYNE | 1 | 7 |
| Donald Parfet | 1 | 5 |
| Patrick Morand | 1 | 5 |
| Douglas Morton | 1 | 3 |
| BRIAN YOUNG | 1 | 3 |
| Peter Vitulli | 1 | 3 |
| John B. Payne | 1 | 3 |
| JAMES KOZIARZ | 1 | 2 |
| Andrew Dahl | 1 | 2 |
| Howard Baer | 1 | 2 |
| Nola E. Masterson | 1 | 2 |
| Nola Masterson | 1 | 2 |
| Keith R. Marchiando | 1 | 2 |
| Andrew A Dahl | 1 | 2 |
| Charles Hall | 1 | 2 |
| John Crissman | 1 | 1 |
| Phillip Long | 1 | 1 |
| Allison A. Cornell | 1 | 1 |
| Christopher D. Maggiore | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.